Atrial Fibrillation and the Risk for Neurological Complications
1 other identifier
observational
1,000
1 country
1
Brief Summary
B8: Atrial fibrillation and the risk of neurological complications Twenty-five thousand acute strokes are caused by atrial fibrillation every year. But even more frequent than symptomatic strokes are silent infarctions of the brain. Silent strokes remain undetected in most cases, but cumulate over time and progressively impair cognition. The impact of atrial fibrillation on subacute brain infarctions is not yet known. Moreover, it has not been elucidated so far how effective different therapeutic strategies in the treatment of atrial fibrillation prevent cognitive impairment. Thus, this study aims at evaluating the influence of different types of atrial fibrillation on silent strokes and the related impairment in cognitive functions. Other risk factors and cardiovascular diseases that are known to provoke the development of strokes will be assessed as well. So, it will be possible to isolate the contribution of atrial fibrillation to silent strokes and related cognitive impairment in segregation to other relevant factors. AF patients and controls will be examined twice in two years in order to evaluate the role of atrial fibrillation and differential therapeutic interventions with regard to the progression of silent strokes and cognitive impairment in a within subject-design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedFirst Submitted
Initial submission to the registry
July 25, 2006
CompletedFirst Posted
Study publicly available on registry
July 27, 2006
CompletedApril 19, 2007
April 1, 2007
July 25, 2006
April 18, 2007
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of permanent, paroxysmal or episodic atrial fibrillation in the past or at present
You may not qualify if:
- Pacemaker
- Metal implants
- History of acute stroke
- Diagnosis of vascular or degenerative dementia
- History of brain tumors
- History of severe brain injury
- History of psychiatric disorders
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Münster, Dept. of Neurology
Münster, North Rhine-Westphalia, 48149, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Knecht, Prof.
University Hospital Münster, Department of Neurology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 25, 2006
First Posted
July 27, 2006
Study Start
January 1, 2004
Last Updated
April 19, 2007
Record last verified: 2007-04